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ABSTRACT
Coronary artery bypass graft (CABG) intervention, particularly anastomosis site intervention, is challenging for interven-
tional cardiologists. A paclitaxel-eluting balloon catheter (SeQuent Please) is a recently-introduced device capable of deliver-
ing paclitaxel homogeneously into the targeted vessel wall. We herein report our experience with two cases. In the first case, 
coronary angiography showed significant stenosis at the site of anastomosis between the saphenous vein graft and the left 
anterior descending artery (LAD). In the second case, coronary angiography showed significant stenosis at the site of anasto-
mosis between the left internal mammary artery and the LAD. We performed percutaneous intervention of these CABG anas-
tomoses using paclitaxel-eluting balloon catheters, and obtained favorable angiographic and clinical outcomes. (Korean 
Circ J 2011;41:685-688)
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Introduction
Coronary artery bypass surgery is the treatment of choice 
in patients with left main coronary artery disease or triple-ves-
sel disease.
1)2) However, graft occlusion remains a challenge for 
interventional cardiologists, particularly in patients who de-
velop occlusion at the site of anastomosis. Recently, a paclita-
xel-eluting balloon catheter (SeQuent Please, B. Braun, Mel-
sungen, Germany) was introduced and showed favorable re-
sults in the management of in-stent restenosis, small vessel 
disease, and bifurcation lesions.
3-5) We herein report two cases 
of percutaneous intervention for the management of coro-
nary artery bypass graft (CABG) anastomosis using paclita-
xel-eluting balloon catheters. 
Cases
Case 1 
A 77 year-old male patient was admitted through the out-
patient clinic with a 1-month history of chest pain on exer-
tion. His medical history included hypertension for 15 years. 
He underwent coronary artery bypass surgery for myocardial 
infarction 5 years previously. A saphenous vein graft (SVG) 
was anastomosed with the ascending aorta and the distal left 
anterior descending artery (LAD). Post-operatively, he had 
been taking aspirin, clopidogrel, atorvastatin, and nitrates. 
Five months prior to his presentation, percutaneous balloon 
angioplasty was performed with a 3.0×20 mm Ryujin bal-
loon (Terumo, Tokyo, Japan) at 10 atmospheres because cor-
onary angiography showed significant stenosis of the anas-
tomosis between the SVG and the distal LAD. On admission, 
his blood pressure and pulse rate were 110/76 mm Hg and 53/ 
min, respectively. Electrocardiography (ECG) showed sinus 
bradycardia, left ventricular hypertrophy with strain, and Q 
waves in leads III and aVF. The levels of creatinine kinase-
MB (CK-MB) and troponin-I were within the normal limits. 686   Percutaneous Intervention of Coronary Artery Bypass Graft Anastomoses
Echocardiography demonstrated an ejection fraction of 54% 
and hypokinesia of the inferior wall. Left coronary angiogra-
phy showed significant stenosis of the left main coronary ar-
tery, total occlusion of the proximal LAD and the proximal 
left circumflex artery (LCx). Right coronary angiography sh-
owed significant diffuse stenosis from the proximal-to-distal 
right coronary artery (RCA). SVG angiography showed sig-
nificant restenosis of the anastomosis between the SVG and 
the distal LAD, and significant stenosis in the distal LAD. We 
decided to perform on-site percutaneous intervention of the 
anastomosis. A 6-Fr Judkins right guiding catheter (Cordis, 
Johnson & Johnson, Bridgewater, NJ, USA) was engaged in 
the SVG through the right femoral artery. A 0.014-inch Fi-
elder FC wire (Ashahi Intecc, Nagoya, Japan) was placed in 
the SVG to the LAD. We performed angioplasty with a 2.5× 
15 mm Ryujin balloon (Terumo) at 8 atmospheres, and a 
2.75×15 mm SeQuent Please paclitaxel-eluting balloon ca-
theter (B. Braun, Melsungen, Germany) at 7 atmospheres. Post-
intervention angiography showed minimal residual stenosis 
and Thrombolysis in Myocardial Infarction (TIMI) grade III 
blood flow. Four days after the intervention, he was disch-
arged without chest pain. Four months later, repeat coronary 
angiography showed no restenosis at the site of the anasto-
mosis (Fig. 1). 
Case 2 
A 71-year-old female patient was admitted through the 
outpatient clinic with a 3-month history of chest pain on ex-
ertion. Her past medical history included hypertension for 12 
years. She underwent coronary artery bypass surgery for myo-
cardial infarction secondary to triple-vessel disease 2 years 
prior to admission. She was managed by anastomosing the 
left internal mammary artery (LIMA) with the distal LAD. 
Two SVGs were anastomosed with the obtuse marginal br-
anch and distal RCA. Post-operatively, she was commenced 
on aspirin, clopidogrel, pitavastatin, and nitrates. On admis-
sion, her blood pressure and pulse rate were 124/70 mm Hg 
and 75/min, respectively. ECG showed normal sinus rhythm. 
Levels of CK-MB and troponin-I were within the normal li-
mits. Echocardiography showed an ejection fraction of 53% 
and hypokinesia of the inferior wall. Left coronary angiogra-
phy showed total occlusion of the proximal LAD and diffuse 
Fig. 1. A: saphenous vein graft (SVG) angiography of the patient in Case 1 showed significant restenosis of anastomosis between the SVG 
and the distal left anterior descending artery (LAD), and significant stenosis in the distal LAD. B: post-intervention angiography showed 
minimal residual stenosis and blood flow of Thrombolysis in Myocardial Infarction (TIMI) grade III. C: four-month follow-up angiography 
showed no restenosis and blood flow of TIMI grade III.
A   B   C  
Fig. 2. A: left internal mammary artery (LIMA) angiography of patient in Case 2 showed significant stenosis of the mid left anterior descend-
ing artery (LAD) and anastomosis between the LIMA and the distal LAD. B: post-intervention angiography showed minimal residual steno-
sis and blood flow of Thrombolysis in Myocardial Infarction (TIMI) grade III. C: six-month follow-up angiography showed no restenosis and 
blood flow of TIMI grade III.
A   B   C  Jae-Sun Uhm, et al.   687
stenosis of the proximal LCx. Right coronary angiography 
showed diffuse stenosis of the proximal-to-mid RCA and 
total occlusion of the distal RCA. LIMA angiography show-
ed significant stenoses of the mid LAD and anastomosis be-
tween the LIMA and the distal LAD. SVG angiography sh-
owed two patent SVGs. The following day she underwent myo-
cardial perfusion scan, which confirmed perfusion defect of 
the anteroseptal wall in the adenosine stress phase. We con-
sidered mid LAD stenosis, and the anastomosis between the 
LIMA and LAD as the cause of her clinical state, and decided 
to perform percutaneous intervention at these sites. A 6-Fr 
Judkins right guiding catheter (Cordis) was engaged in the 
SVG through the right femoral artery. A 0.014 inch Fielder FC 
wire (Ashahi Intecc) was placed in the LIMA to mid LAD. 
We performed angioplasty of the anastomosis with a 2.0×15 
mm Maverick balloon (Boston Scientific, Natick, MA, USA) 
at 6 atmospheres. We attempted to deliver a drug-eluting stent 
into the lesion, but it would not advance beyond a site just be-
fore the lesion. Therefore, we replaced a drug-eluting stent 
with a 2.5×17-mm SeQuent Please paclitaxel-eluting balloon 
catheter (B. Braun) at 7 atmospheres. We performed angio-
plasty of the mid LAD with a 2.0×15 mm Maverick balloon 
(Boston Scientific) at 8 atmospheres. Post-intervention angi-
ography showed minimal residual stenosis and blood flow of 
TIMI grade III. The patient was discharged three days after 
the intervention without chest pain. Six months later, coronary 
angiography showed no restenosis of the anastomosis (Fig. 2).
Discussion
Graft occlusion can be troublesome in patients who have 
undergone coronary artery bypass surgery. Patency rates de-
pend on bypass conduits. Patency (stenosis <20%) rates of a LI-
MA at 5 and 10 years have been reported to be 98% and 95%, 
respectively, while the patency rates of a SVG are 95% and 
71%, respectively.
6) Patency rate of a radial artery graft at 5 
years is 95% in younger patients, (<70 years) and 86% in older 
patients (≥70 years).
7) 
Treatment options of graft occlusion include percutaneous 
balloon angioplasty, percutaneous stenting, and redo-CABG. 
Because redo-CABG is associated with high mortality rate,
8) 
percutaneous intervention is preferred. Because cardiac surge-
ons have been using SVG for a long time, and because SVG 
has a relatively low patency rate, interventional cardiologists 
should occasionally perform SVG intervention. However, SVG 
intervention is challenging because of the high rate of peri-
procedural myocardial infarction and restenosis.
9) In addition, 
a stent in the SVG can fracture due to movement of the SVG.
10) 
Recent reports have demonstrated that drug-eluting stents 
and embolic protection devices lead to good results in the ma-
nagement of SVG disease.
11)12) Because a LIMA graft has high 
patency rate, LIMA intervention is not performed frequently. 
For LIMA intervention, favorable results can be obtained by 
stenting.
13) 
Intervention of distal anastomosis is more challenging, be-
cause distal anastomosis is bifurcating, and different vessel 
response to intraluminal ballooning exists between the graft 
and native coronary artery. Standard treatment modalities of 
distal anastomosis disease have not been established. 
The recently-released paclitaxel-eluting balloon catheter, 
which is based on a new matrix-coating technique, is poly-
mer-free and can deliver paclitaxel homogeneously into the 
targeted vessel wall. Because there are no polymers on the 
paclitaxel-eluting balloon, the risk of intracoronary throm-
bosis is lower than that with a drug-eluting stent. Therefore, 
the need for long-term dual anti-platelet therapy should be 
reduced. According to experienced operators, deliverability of 
a paclitaxel-eluting balloon is better than a drug-eluting stent. 
It has been reported that paclitaxel-eluting balloon catheters 
can be a treatment option of in-stent restenosis, small vessel 
disease, and bifurcating lesions.
3-5) In the PEPCAD II trial, 
paclitaxel-eluting balloons had comparable binary restenosis 
rate to paclitaxel-eluting stents for the treatment of coronary 
in-stent restenosis at 6-month follow-up.
14) However, in the 
PICCOLETO study, paclitaxel-eluting balloon catheters failed 
to show superior angiographic and clinical outcomes for the 
intervention of small coronary arteries compared to pacli-
taxel-eluting stents.
15) The potential use and long-term reste-
nosis rate of paclitaxel-eluting balloon catheters have not been 
studied. 
We successfully managed two cases of percutaneous inter-
vention of distal anastomoses of CABGs with paclitaxel-
eluting balloon catheters. Short-term angiographic and clini-
cal outcomes were favorable. In the cases, because of differ-
ence in the proximal and distal reference diameters and be-
cause of the acute angles between the proximal and distal ar-
teries, risks of stent mal-apposition and fracture is high fol-
lowing stenting of the anastomosis sites. Therefore, paclitaxel-
eluting balloons were better choices than conventional stents. 
Because of good deliverability and comparable restenosis 
rate,
3-5) intervention with a paclitaxel-eluting balloon cathe-
ter can be an option for the treatment of CABG distal anasto-
mosis. Long-term randomized studies are required to evalu-
ate paclitaxel-eluting balloon catheters for the intervention 
of CABG. 
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